Published in Biol Psychiatry on December 01, 2003
Neurocircuitry of mood disorders. Neuropsychopharmacology (2010) 5.57
The subgenual anterior cingulate cortex in mood disorders. CNS Spectr (2008) 3.40
Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev (2009) 2.44
Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci U S A (2004) 2.19
Elevated striatal and decreased dorsolateral prefrontal cortical activity in response to emotional stimuli in euthymic bipolar disorder: no associations with psychotropic medication load. Bipolar Disord (2008) 1.71
Life events in bipolar disorder: towards more specific models. Clin Psychol Rev (2005) 1.42
An fMRI study of the neural correlates of incidental versus directed emotion processing in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry (2009) 1.42
Functional connectivity between ventral prefrontal cortex and amygdala at low frequency in the resting state in bipolar disorder. Psychiatry Res (2010) 1.35
Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J Psychiatry Neurosci (2005) 1.35
Regional brain changes in bipolar I depression: a functional magnetic resonance imaging study. Bipolar Disord (2008) 1.25
Identifying functional neuroimaging biomarkers of bipolar disorder: toward DSM-V. Schizophr Bull (2007) 1.24
The psychopathology and treatment of bipolar disorder. Annu Rev Clin Psychol (2006) 1.18
Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder. Psychiatry Res (2008) 1.17
Frontal-amygdala connectivity alterations during emotion downregulation in bipolar I disorder. Biol Psychiatry (2012) 1.11
Deficits in GABA(B) receptor system in schizophrenia and mood disorders: a postmortem study. Schizophr Res (2011) 1.10
An fMRI study of working memory in persons with bipolar disorder or at genetic risk for bipolar disorder. Am J Med Genet B Neuropsychiatr Genet (2010) 1.05
Neuroimaging in bipolar disorder: a critical review of current findings. Curr Psychiatry Rep (2007) 1.02
A Ventral Prefrontal-Amygdala Neural System in Bipolar Disorder: A View from Neuroimaging Research. Acta Neuropsychiatr (2009) 1.01
Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex. J Am Acad Child Adolesc Psychiatry (2007) 0.98
Expression of GABAA α2-, β1- and ε-receptors are altered significantly in the lateral cerebellum of subjects with schizophrenia, major depression and bipolar disorder. Transl Psychiatry (2013) 0.98
The effect of mood on sleep onset latency and REM sleep in interepisode bipolar disorder. J Abnorm Psychol (2009) 0.96
Integrated neurobiology of bipolar disorder. Front Psychiatry (2014) 0.93
Functional neuroanatomy of bipolar disorder: structure, function, and connectivity in an amygdala-anterior paralimbic neural system. Bipolar Disord (2012) 0.93
Lithium alters brain activation in bipolar disorder in a task- and state-dependent manner: an fMRI study. Ann Gen Psychiatry (2005) 0.93
Functional anatomy of autobiographical memory recall deficits in depression. Psychol Med (2011) 0.93
Mapping the "Depression Switch" During Intraoperative Testing of Subcallosal Cingulate Deep Brain Stimulation. JAMA Neurol (2015) 0.91
Dissociable patterns of medial prefrontal and amygdala activity to face identity versus emotion in bipolar disorder. Psychol Med (2012) 0.90
Trait and state corticostriatal dysfunction in bipolar disorder during emotional face processing. Bipolar Disord (2012) 0.87
Cortical thickness differences between bipolar depression and major depressive disorder. Bipolar Disord (2014) 0.85
Affective reactivity in response to criticism in remitted bipolar disorder: a laboratory analog of Expressed Emotion. J Clin Psychol (2009) 0.85
Increased olfactory sensitivity in euthymic patients with bipolar disorder with event-related episodes compared with patients with bipolar disorder without such episodes. J Psychiatry Neurosci (2006) 0.81
The neurocognitive functioning in bipolar disorder: a systematic review of data. Ann Gen Psychiatry (2015) 0.81
Cognitive neuroscience and brain imaging in bipolar disorder. Dialogues Clin Neurosci (2008) 0.79
Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder. Sci Rep (2012) 0.78
Structural equation modeling and principal component analysis of gray matter volumes in major depressive and bipolar disorders: differences in latent volumetric structure. Psychiatry Res (2010) 0.78
A Retrospective Examination of Sleep Disturbance across the Course of Bipolar Disorder. J Sleep Disord Ther (2015) 0.77
Protein expression of targets of the FMRP regulon is altered in brains of subjects with schizophrenia and mood disorders. Schizophr Res (2015) 0.76
State and Training Effects of Mindfulness Meditation on Brain Networks Reflect Neuronal Mechanisms of Its Antidepressant Effect. Neural Plast (2016) 0.75
Emotion in Aging and Bipolar Disorder: Similarities, Differences, and Lessons for Further Research. Emot Rev (2013) 0.75
Toward discovery science of human brain function. Proc Natl Acad Sci U S A (2010) 15.22
Deep brain stimulation for treatment-resistant depression. Neuron (2005) 12.39
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies. Bipolar Disord (2005) 4.94
Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci (2012) 4.71
Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci (2007) 4.46
Toward a neuroimaging treatment selection biomarker for major depressive disorder. JAMA Psychiatry (2013) 4.12
A whole brain fMRI atlas generated via spatially constrained spectral clustering. Hum Brain Mapp (2011) 3.75
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord (2009) 3.56
Neurobiological mechanisms of the placebo effect. J Neurosci (2005) 3.41
A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg (2011) 3.30
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord (2012) 3.01
Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry (2008) 3.00
Posttraumatic stress disorder: a state-of-the-science review. J Psychiatr Res (2005) 2.61
Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. Am J Psychiatry (2011) 2.46
Harnessing neuroplasticity for clinical applications. Brain (2011) 2.45
Disease state prediction from resting state functional connectivity. Magn Reson Med (2009) 2.37
Misuse of the FDA's humanitarian device exemption in deep brain stimulation for obsessive-compulsive disorder. Health Aff (Millwood) (2011) 2.34
VNS therapy in treatment-resistant depression: clinical evidence and putative neurobiological mechanisms. Neuropsychopharmacology (2006) 2.24
Assessing the 'true' effect of active antidepressant therapy v. placebo in major depressive disorder: use of a mixture model. Br J Psychiatry (2011) 2.23
Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. Am J Psychiatry (2002) 2.23
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord (2009) 2.17
Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry (2007) 2.15
Novel investigational drugs targeting IL-6 signaling for the treatment of depression. Expert Opin Investig Drugs (2015) 2.07
A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry (2008) 1.90
Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry (2005) 1.85
Risk and resilience markers in bipolar disorder: brain responses to emotional challenge in bipolar patients and their healthy siblings. Am J Psychiatry (2006) 1.84
Subcallosal cingulate deep brain stimulation for treatment-resistant unipolar and bipolar depression. Arch Gen Psychiatry (2012) 1.83
Corticolimbic brain reactivity to social signals of threat before and after sertraline treatment in generalized social phobia. Biol Psychiatry (2012) 1.78
Association of the malnutrition-inflammation score with clinical outcomes in kidney transplant recipients. Am J Kidney Dis (2011) 1.77
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord (2009) 1.64
Osmotic-release oral system methylphenidate augmentation of antidepressant monotherapy in major depressive disorder: results of a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry (2008) 1.61
Stuck in a rut: rethinking depression and its treatment. Trends Neurosci (2010) 1.60
Neural stimulation successfully treats depression in patients with prior ablative cingulotomy. Am J Psychiatry (2008) 1.49
Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder. Bipolar Disord (2008) 1.49
Receptor architecture of human cingulate cortex: evaluation of the four-region neurobiological model. Hum Brain Mapp (2009) 1.48
Deep brain stimulation for psychiatric disorders. Annu Rev Neurosci (2011) 1.47
Should Depressive Syndromes Be Reclassified as "Metabolic Syndrome Type II"? Ann Clin Psychiatry (2007) 1.46
A novel examination of atypical major depressive disorder based on attachment theory. J Clin Psychiatry (2009) 1.45
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007. Bipolar Disord (2006) 1.43
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale. CMAJ (2005) 1.42
Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. J Neurosurg (2003) 1.39
Defining the neural circuitry of depression: toward a new nosology with therapeutic implications. Biol Psychiatry (2007) 1.39
The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf (2006) 1.37
Is the cerebellum relevant in the circuitry of neuropsychiatric disorders? J Psychiatry Neurosci (2005) 1.35
Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. Arch Gen Psychiatry (2009) 1.33
Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry (2003) 1.30
A randomized controlled trial of psychoeducation or cognitive-behavioral therapy in bipolar disorder: a Canadian Network for Mood and Anxiety treatments (CANMAT) study [CME]. J Clin Psychiatry (2012) 1.30
Neuromodulation for treatment-refractory major depressive disorder. CMAJ (2013) 1.29
An fMRI study investigating cognitive modulation of brain regions associated with emotional processing of visual stimuli. Neuropsychologia (2003) 1.29
Hormone replacement therapy and antidepressant prescription patterns: a reciprocal relationship. CMAJ (2005) 1.25
Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann Clin Psychiatry (2005) 1.22
Real-World Data on SSRI Antidepressant Side Effects. Psychiatry (Edgmont) (2009) 1.21
Medical comorbidity in bipolar disorder: implications for functional outcomes and health service utilization. Psychiatr Serv (2006) 1.17
Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord (2009) 1.17
Predictors of nonresponse to cognitive behavioural therapy or venlafaxine using glucose metabolism in major depressive disorder. J Psychiatry Neurosci (2009) 1.16
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults. V. Complementary and alternative medicine treatments. J Affect Disord (2009) 1.14
The prevalence and impact of migraine headache in bipolar disorder: results from the Canadian Community Health Survey. Headache (2006) 1.13
Treatment resistant depression as a failure of brain homeostatic mechanisms: implications for deep brain stimulation. Exp Neurol (2009) 1.12
Depression beliefs, treatment preference, and outcomes in a randomized trial for major depressive disorder. J Psychiatr Res (2011) 1.12
Are antidepressants as effective as claimed? Yes, but.... Can J Psychiatry (2007) 1.11
Personality and differential treatment response in major depression: a randomized controlled trial comparing cognitive-behavioural therapy and pharmacotherapy. Can J Psychiatry (2008) 1.10
Decreased cortical representation of genital somatosensory field after childhood sexual abuse. Am J Psychiatry (2013) 1.10
Dimensional personality traits and treatment outcome in patients with major depressive disorder. J Affect Disord (2007) 1.10
Obesity in bipolar disorder and major depressive disorder: results from a national community health survey on mental health and well-being. Can J Psychiatry (2006) 1.09
Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities. Expert Opin Pharmacother (2006) 1.08
The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: an evolutionary perspective. Biol Psychiatry (2004) 1.07
Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials (2012) 1.06
Medical comorbidity in bipolar disorder: re-prioritizing unmet needs. Curr Opin Psychiatry (2007) 1.06
Antidepressant side effects in depression patients treated in a naturalistic setting: a study of bupropion, moclobemide, paroxetine, sertraline, and venlafaxine. Can J Psychiatry (2002) 1.03
Tractography-activation models applied to subcallosal cingulate deep brain stimulation. Brain Stimul (2013) 0.99
The association between conventional antidepressants and the metabolic syndrome: a review of the evidence and clinical implications. CNS Drugs (2010) 0.99
Substance use disorders and overweight/obesity in bipolar I disorder: preliminary evidence for competing addictions. J Clin Psychiatry (2007) 0.98
The 5-factor model of personality and antidepressant medication compliance. Can J Psychiatry (2004) 0.98
The hepatic safety profile of duloxetine: a review. Expert Opin Drug Metab Toxicol (2008) 0.97
Topiramate versus bupropion SR when added to mood stabilizer therapy for the depressive phase of bipolar disorder: a preliminary single-blind study. Bipolar Disord (2002) 0.97
Neuropsychological impact of Cg25 deep brain stimulation for treatment-resistant depression: preliminary results over 12 months. J Nerv Ment Dis (2008) 0.96
Exploratory structural equation modeling of resting-state fMRI: applicability of group models to individual subjects. Neuroimage (2009) 0.96
Childhood maltreatment and differential treatment response and recurrence in adult major depressive disorder. J Consult Clin Psychol (2012) 0.96
Mood disorders and obesity: understanding inflammation as a pathophysiological nexus. Neuromolecular Med (2010) 0.95
Beyond Depression: Towards a Process-Based Approach to Research, Diagnosis, and Treatment. Clin Psychol (New York) (2011) 0.95
Effects of combined pharmacotherapy and psychotherapy for improving work functioning in major depressive disorder. Br J Psychiatry (2013) 0.94
Personality influences limbic-cortical interactions during sad mood induction. Neuroimage (2003) 0.94
The effect of vilazodone on sexual function during the treatment of major depressive disorder. J Sex Med (2012) 0.93
Deep brain stimulation for treatment-resistant depression. Am J Psychiatry (2010) 0.92
Validation of an IVRS version of the MADRS. J Psychiatr Res (2005) 0.92
The effect of antidepressants on lipid homeostasis: a cardiac safety concern? Expert Opin Drug Saf (2006) 0.91
Anxiety disorders and bipolar disorder: a review. Bipolar Disord (2006) 0.91
The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression? Neurotoxicology (2009) 0.91
Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry (2014) 0.89
Gender as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression: an "individual patient data" meta-analysis. Depress Anxiety (2014) 0.89
Thiazolidinediones: novel treatments for cognitive deficits in mood disorders? Expert Opin Pharmacother (2007) 0.89
Novel therapeutic targets in depression: minocycline as a candidate treatment. Behav Brain Res (2012) 0.89
Frontal theta cordance predicts 6-month antidepressant response to subcallosal cingulate deep brain stimulation for treatment-resistant depression: a pilot study. Neuropsychopharmacology (2012) 0.89
Calculated bioavailable testosterone levels and depression in middle-aged men. Psychoneuroendocrinology (2006) 0.89